Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Oncology Briefings™: Novel Antibody-Drug Conjugates in the Treatment of Advanced or Refractory HER2+ Breast Cancers

Release Date: May 29, 2020
Expiration Date: May 29, 2021

Activity Overview

This online activity is designed to provide a concise and focused overview on an important clinical topic and includes information on the management of HER2-posiitve (HER2+) metastatic breast cancer, including considerations in HER2 testing, recent regulatory approvals and their impact on treatment decision-making along with supporting efficacy and safety data, and an overview of future directions and investigational therapies for this breast cancer subtype. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Acknowledgement of Support

This activity is supported by an educational grant from AstraZeneca.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational initiative is directed toward medical oncologists who treat patients with breast cancer. Nurse practitioners, nurses, physician assistants, pharmacists, investigators, fellows, and other health care professionals interested in the treatment of breast cancer will also be invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Interpret HER2 testing results based on current expert guidelines in order to accurately determine HER2 status in patients with breast cancer
  • Integrate recent clinical trial results with HER2-targeted agents into personalized treatment algorithms to optimize outcomes for patients with early-stage or advanced/metastatic HER2+ or HER2-low breast cancer
  • Discuss ongoing clinical trials and the potential impact of emerging data regarding investigational approaches on evolving treatment paradigms for managing HER2+ or HER2-low breast cancer

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Ian Krop, MD, PhD
Ian Krop, MD, PhD
Associate Chief, Division of Breast Oncology
Senior Physician
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures: Grant/Research Support: Genentech; Pfizer; Daiichi-Sankyo. Consultant: Genentech; Daiichi-Sankyo; Macrogenics, Context Therapeutics; Taiho Oncology; Merck; Novartis; BMS.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By